Project Grant R33AA031474
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Washington $670,594 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop and test a personalized text message intervention for young adults addressing anticipated drinking events and protective behavioral strategy use. The intervention delivers a theoretically and clinically informed 3-week text message program tailored to individual anticipated drinking occasions and harm-reduction...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Washington University $555,331 on August 13, 2026, under the Alcohol Research Programs (CFDA 93.273) to examine the metabolic-epigenetic regulation of alcohol intake and associated molecular mechanisms. The funded research explores how alcohol-derived acetate generated during alcohol metabolism affects brain histone acetylation and subsequently influences alcohol intake behavior. The project builds on preliminary findings...
- The National Institute on Alcohol Abuse and Alcoholism awarded Yale University $182,183 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop artificial intelligence agents that generate personalized, multimedia cognitive behavioral therapy content for alcohol use disorder treatment, targeting English speakers and Spanish speakers. The project will create AI-generated CBT content delivered via smartphone to address high-risk drinking periods, such as weekends. The...
- The National Institute on Alcohol Abuse and Alcoholism awarded Lovelace Biomedical Research Institute $1.705 million on September 25, 2025, under the Alcohol Research Programs grant (CFDA 93.273) to conduct a randomized controlled trial of music training for children with Fetal Alcohol Spectrum Disorder. The research examines whether music training improves brain function and targeted cognitive skills in children with FASD through enhancement of predictive coding—the brain's capacity to...
- The National Institute on Alcohol Abuse and Alcoholism awarded Trustees of Tufts College $686,774 on July 20, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct behavioral neurobiology research on stress, alcohol responsivity, and alcohol drinking patterns. The research uses rodent models to investigate how stress exposure alters sensitivity to alcohol's aversive effects and the neural circuits involved. The study employs classical and operant conditioning paradigms combined with...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Missouri System $1,413,058 on September 10, 2025, under the Alcohol Research Programs authority (CFDA 93.273) to conduct a longitudinal ecological momentary assessment study of alcohol consumption patterns and contexts across the transition to legal drinking age. The study employs a burst design to track 20-year-olds sampled from Missouri driver's license records (birth years 2005–2008, rural and small metro...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Research Foundation For The State University Of New York $628,150 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct the Honoring and Examining Alcohol Recovery (HEAR) Study, a longitudinal examination of recovery capital and its association with recovery outcomes. The award funds research to advance understanding of recovery capital—the social, physical, human, and cultural resources that...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Leland Stanford Junior University $588,650 on July 15, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct a pragmatic three-arm randomized controlled trial evaluating digital interventions for alcohol use in emergency department settings. The trial will enroll 750 adult ED patients with risky alcohol use and randomize them to standard care, a conversational AI agent (MICA) delivering motivational...
- The National Institute on Alcohol Abuse and Alcoholism awarded New York University School of Medicine $2.920164 million on August 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop and evaluate a precision prevention approach for identifying and addressing behavioral health treatment gaps that drive suicide risk. The project will identify subgroups at highest risk of suicidal thoughts and behaviors, characterize which combinations of mental and substance use disorders place...
- The National Institute on Alcohol Abuse and Alcoholism awarded Here & Now Systems LLC $306,746 on July 1, 2026, to develop an enhanced version of the STEP AWAY Alcohol Manager (SAAM), a mobile health intervention for alcohol use disorder treatment, under the Alcohol Research Programs (CFDA 93.273). SAAM is a mobile application that delivers personalized alcohol intervention through integration of artificial intelligence and biometric monitoring. The Phase I project incorporates multi-agent...
The National Institute on Alcohol Abuse and Alcoholism awarded Washington State University $498,203 under the Alcohol Research Programs (CFDA 93.273) on August 1, 2026, to develop a just-in-time adaptive music-listening mobile health intervention for stress reduction among individuals in early recovery from alcohol use disorder. The research aims to create the first music-listening intervention leveraging passive sensing and machine learning to automatically predict and respond to moments of acute stress during the first 90 days after detoxification from alcohol. The work addresses the gap between high prevalence of alcohol use disorder among young adults and low treatment-seeking rates, with disruption of the stress response system identified as a key contributor to relapse risk. The project is structured in two phases: formative research with recently treated young adults in early sobriety to identify music features most effective for stress reduction in real-world ambulatory settings, and development of mobile health technology using passive sensing and machine learning to automatically predict and intervene during high-stress moments. Performance occurs at Washington State University in Pullman, Washington, with a period of performance from August 1, 2026, through July 31, 2029. The award is classified as a Project Grant under the Alcohol Research Programs, which supports research across biomedical, genetic, psychological, environmental, and health services domains to develop improved treatment methods and prevention strategies for alcoholism and alcohol-related problems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $498.2k | 8/5/26 |